Chromium-Based Browsers Will Ignore Google’s Ad-Blocking Ban

Jun 11, 2019

Brave Opera and Vivaldi will not implement Google’s changes that will cripple ad-blockers.

Commercial web browsers including Brave, Opera, and Vivaldi won’t be disabling ad blocker extensions as desired by Google. These browsers are based on the the same open source codebase that is used with Google Chrome. Google maintains an open source project called Chromium as the base of its Chrome browsers.

According to ZDnet, “At the end of May, Google made a new announcement in which it said that the old technology that ad blockers were relying on would only be available for Chrome enterprise users, but not for regular users.”

Chromium has become standard for web browsers; except for Safari and Firefox, almost everyone is using Chromium--including Microsoft Edge. Chromium derivates Brave, Opera, and Vivaldi have said they will not follow Google into crippling ad-blocking.

Related content

  • NEWS

    Updates on technologies, trends, and tools

  • LibRedirect

    The LibRedirect browser extension redirects YouTube, Instagram, Reddit, TikTok, and other services to alternative, privacy-friendly front ends.

  • Microsoft Gets an Open Source Web Browser

    The company will use Google Chromium web browser as the foundation for its next browser.

  • Anonymous Browsing

    The major web browsers claim to protect users against data collectors and the advertising industry; however, promises are often quite different from reality.

  • News

    GitHub offers free private repositories, Linus Torvalds welcomes 2019 with Linux 5, SQLite database vulnerable, hacks abound, Kubernetes vulnerability found and fixed, and Dolphin announces new switch for composable architectures. 

comments powered by Disqus
Subscribe to our Linux Newsletters
Find Linux and Open Source Jobs
Subscribe to our ADMIN Newsletters

Support Our Work

Linux Magazine content is made possible with support from readers like you. Please consider contributing when you’ve found an article to be beneficial.

Learn More

News